Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy Volunteers

Inclusion Criteria

• •Normal healthy volunteers.
• •Females must be of non-childbearing potential.
• •If engaged in sexual relations with a female of child-bearing potential, males must be surgically sterile or must be willing to use a highly effective method of contraception throughout their study participation and for at least 6 months after the last dose of study drug.
• •Must have 2 regions on lower back/upper buttocks that are free of striae, scars, tattoos, or other skin pathologies.
• •Must have no conditions that could increase risk of abnormal or delayed healing.